Ofev Improves IPF Patients’ Lung Function Over the Long Term, Trial and Extension Show
Idiopathic Pulmonary Fibrosis, News
Long-term treatment with Boehringer Ingelheim‘s Ofev (nintedanib) improved the lung function and reduced the flare-ups of people with idiopathic pulmonary fibrosis, results of a Phase 2 clinical trial and its extension show. ... Read more